Insights On Outsourced Drug Development
-
Formulating Better ASDs And mAbs: Advances In Applied Nanotechnology
5/1/2024
Learn about new data on nanotechnology formulations for multiple dose forms and routes of delivery, including oral, long-acting injectables, inhalation, and ophthalmic.
-
Creating An Effective Pre-Clinical Model Of Bone Marrow
4/9/2024
Uncover how the Bone Marrow-Chip (BM-Chip) can be used as an effective model for studying human bone marrow pathophysiology and explore its range of applications in the field of medicine.
-
Effect Of Moisture And Substrate Material On Wall Friction Angle Of Powder
4/6/2023
Powder rheology is a useful tool for formulating and optimizing pharmaceutical tablet processing conditions. Investigate the influence of moisture content and substrate material on carboxymethyl cellulose powder wall friction.
-
Improving Workflow Automation And Process Control
10/17/2022
Learn about optimizing your T cell manufacturing process and reducing operating costs with rocking bioreactors using CTS OpTmizer T Cell Expansion SFM.
-
Exploring Neuroinflammation, Neurodegeneration With A Brain Organ-Chip
4/9/2024
Examine how Organ-on-a-Chip technology, accurately mimicking human neuroinflammation, offers promising human-relevant avenues for neurodegenerative disease research and therapeutic development.
-
SPR Assays To The Assess Similarity Between Innovator And Biosimilar Versions of Nivolumab (Opdivo®)
9/2/2022
Learn more about developed and qualified SPR assays to characterize the binding and affinity of biosimilar and innovator nivolumab for all seven Fc gamma receptors, FcRn and PD-1.
-
Accelerator℠ Virtual Reality Training
9/20/2022
The Accelerator Virtual Reality (VR) Training Center offers instant, scalable access to training programs for a wide variety of Pall® technology without the constraints of trainer and equipment availability.
-
Accurate HC-LC Pairing And A Close-To-Nature Solution For bsAbs
9/11/2023
Examine how a proprietary technology ensures high levels of accurate HC-LC pairing without detriment to critical quality attributes such as titer, binding affinity, stability, and immunogenicity.
-
Expanding Home-Based Care With A Next-Gen On-Body Delivery System
10/20/2023
As on-body delivery systems (OBDSs) enable the shift to patient-centric treatment, manufacturers must optimize the device and therapy formulation to minimize the risks and increase adherence.
-
Early Development Considerations For NCE Success: Quality Systems
3/1/2024
Leveraging robust quality systems can improve efficiency throughout the product development lifecycle and help companies avoid unnecessary knowledge and tech transfer, saving both time and cost.